Patent ID: 11951120
Assignee: NANJING GENELEAP BIOTECHNOLOGY CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 18:
19. The method of claim 18, wherein the disorder is selected from the group consisting of: precancerous lesions, cancer, infectious diseases, condylomata acuminate, HPV infection or HPV infection related diseases or conditions, anemia, diabetes, congenital lung disease, asthma, myocardial infarction, melanoma, autoimmune diabetes, autoimmune myocarditis, inflammation, factor VII deficiency, hemophilia A, hemophilia B, factor X deficiency, factor XI deficiency, factor XIII deficiency, von Willebrand disease, protein C deficiency, antithrombin deficiency, fibrinogen deficiency, hereditary angioedema, al-PI deficiency, Gaucher disease, mucopolysaccharidosis I, mucopolysaccharidosis II, mucopolysaccharidosis VI, mucopolysaccharidosis IVA, mucopolysaccharidosis IIIA, Fabry disease, Pompe disease, Niemann-Pick type B disease, alpha-mannosidosis, metachromatic leukodystrophy, LAL deficiency, sucraseisomaltase deficiency, ADA deficiency, primary IGF-1 deficiency, hypophosphatasia, acute intermittent porphyria, X-linked severe combined immunodeficiency (X-SCID), Xeroderma pigmentosum, and immune disorders.